Viscoelastic Emulsion Improved the Bioaccessibility and Oral Bioavailability of Crystalline Compound: A Mechanistic Study Using in Vitro and in Vivo Models.
暂无分享,去创建一个
M. Rogers | Qingrong Huang | Yike Jiang | Yuwen Ting | Y. Lan | Zhenyu Lin | Chunxin Xia | Yaqi Lan
[1] P. Lam,et al. Oral delivery of highly lipophilic poorly water-soluble drugs: spray-dried dispersions to improve oral absorption and enable high-dose toxicology studies of a P2Y1 antagonist. , 2014, Journal of pharmaceutical sciences.
[2] P. Shanthi,et al. Effect of tangeretin, a polymethoxylated flavone on glucose metabolism in streptozotocin-induced diabetic rats. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[3] Chi-Tang Ho,et al. Common delivery systems for enhancing in vivo bioavailability and biological efficacy of nutraceuticals , 2014 .
[4] Chi-Tang Ho,et al. Design of high-loading and high-stability viscoelastic emulsions for polymethoxyflavones , 2013 .
[5] Chi-Tang Ho,et al. Effect of a labile methyl donor on the transformation of 5-demethyltangeretin and the related implication on bioactivity. , 2013, Journal of agricultural and food chemistry.
[6] D. Mcclements,et al. Nanoemulsion-based delivery systems for poorly water-soluble bioactive compounds: Influence of formulation parameters on Polymethoxyflavone crystallization. , 2012, Food hydrocolloids.
[7] Hailong Yu,et al. Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions. , 2012, Journal of agricultural and food chemistry.
[8] Hailong Yu,et al. Development of a food-grade organogel with high bioaccessibility and loading of curcuminoids , 2012 .
[9] B. Min,et al. Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced proliferation and migration of aortic smooth muscle cells by blocking AKT activation. , 2011, European journal of pharmacology.
[10] S. Mertens-Talcott,et al. Pharmacokinetic study of nobiletin and tangeretin in rat serum by high-performance liquid chromatography-electrospray ionization-mass spectrometry. , 2011, Journal of agricultural and food chemistry.
[11] M. Golding,et al. The influence of emulsion structure and stability on lipid digestion , 2010 .
[12] G. Wani,et al. Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. , 2009, Cancer research.
[13] Brahmeshwar Mishra,et al. Lipid--an emerging platform for oral delivery of drugs with poor bioavailability. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[14] J. Koropatnick,et al. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. , 2007, Cancer letters.
[15] C. Porter,et al. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.
[16] Jen-kun Lin,et al. Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells. , 2007, Biochemical pharmacology.
[17] A. Hoffman,et al. Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the Relationship to Intra-Enterocyte Processes in Rats , 2006, Pharmaceutical Research.
[18] Chi-Tang Ho,et al. Hydroxylated polymethoxyflavones and methylated flavonoids in sweet orange (Citrus sinensis) peel. , 2006, Journal of agricultural and food chemistry.
[19] A. Theriault,et al. Modulation of hepG2 cell net apolipoprotein B secretion by the citrus polymethoxyflavone, tangeretin , 2004, Lipids.
[20] Jen-kun Lin,et al. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. , 2002, Carcinogenesis.
[21] D. Dexter,et al. Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease , 2001, Neuroreport.
[22] S. Gupta,et al. Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. , 2001, Biochemical and biophysical research communications.
[23] K. Grohmann,et al. Phenols in citrus peel byproducts. Concentrations of hydroxycinnamates and polymethoxylated flavones in citrus peel molasses. , 2001, Journal of agricultural and food chemistry.
[24] D. Dexter,et al. Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro , 2001, Neuropathology and applied neurobiology.
[25] W. Charman,et al. Lipid-based vehicles for the oral delivery of poorly water soluble drugs , 1997 .
[26] M. Miller,et al. Differential effects of nonhydroxylated flavonoids as inducers of cytochrome P450 1A and 2B isozymes in rat liver. , 1996, Toxicology and applied pharmacology.
[27] T. Hirano,et al. Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. , 1995, British Journal of Cancer.
[28] L. Brissette,et al. An in vitro model to study lipolysis of rat hepatic very low density lipoprotein using cardiac lipoprotein lipase. , 1984, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire.
[29] A. Bast,et al. Bioprocessing of wheat bran improves in vitro bioaccessibility and colonic metabolism of phenolic compounds. , 2009, Journal of agricultural and food chemistry.
[30] Chi-Tang Ho,et al. Validated reversed phase LC method for quantitative analysis of polymethoxyflavones in citrus peel extracts. , 2008, Journal of separation science.
[31] C. Rhodes,et al. Controlled-Release Drug Delivery Systems for Prolonged Gastric Residence: An Overview , 1996 .
[32] C. S. Yang,et al. Effects of bioflavonoids on hepatic P450 activities. , 1995, Xenobiotica; the fate of foreign compounds in biological systems.